These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2485301)

  • 1. [The effect of serial passage of Coxiella burnetii in chick embryos on pathogen phase variability].
    Urvölgyi J
    Tr Inst Im Pastera; 1989; 66():154-9, 175. PubMed ID: 2485301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological consequences of Coxiella burnetii phase variation.
    Quevedo Diaz MA; Lukácová M
    Acta Virol; 1998 Jun; 42(3):181-5. PubMed ID: 9842448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.
    Ftácek P; Skultéty L; Toman R
    J Endotoxin Res; 2000; 6(5):369-76. PubMed ID: 11521057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing of antigenic, imumnogenic and chemical properties of a Coxiella burnetii strain during chick embryo yolk sac passaging.
    Visacká E; Schramek S; Kazár J; Kovácová E; Brezina R
    Acta Virol; 1984 Jul; 28(4):300-8. PubMed ID: 6148855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxiella burnetii phase I and II proteins studied by SDS-page.
    Lukácová M; Kazár J; Gajdosová E
    Acta Virol; 1994 Oct; 38(5):263-7. PubMed ID: 7726000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Properties of phase I purified cellular antigen of Coxiella burnetii].
    Kruszewska D; Rumin W; Tylewska-Wierzbanowska S
    Med Dosw Mikrobiol; 1989; 41(3-4):170-5. PubMed ID: 2484257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of Coxiella burnetii strains for preparation of phase II artificial diagnostic antigen for microagglutination test.
    Urvölgyi J; Brezina R
    Acta Virol; 1979 Sep; 23(5):439-42. PubMed ID: 42306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging.
    Lukácová M; Kazár J; Gajdosová E; Vavreková M
    FEMS Microbiol Lett; 1993 Nov; 113(3):285-9. PubMed ID: 8270193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxiella burnetii antigens for detection of Q fever antibodies by ELISA in human sera.
    Kovácová E; Gallo J; Schramek S; Kazár J; Brezina R
    Acta Virol; 1987 May; 31(3):254-9. PubMed ID: 2888290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies.
    Hotta A; Kawamura M; To H; Andoh M; Yamaguchi T; Fukushi H; Hirai K
    Infect Immun; 2002 Aug; 70(8):4747-9. PubMed ID: 12117996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats.
    Arricau-Bouvery N; Souriau A; Bodier C; Dufour P; Rousset E; Rodolakis A
    Vaccine; 2005 Aug; 23(35):4392-402. PubMed ID: 16005747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of a serological study of Coxiella burnetii in domestic animals in Albania.
    Cekani M; Papa A; Kota M; Velo E; Berxholi K
    Vet J; 2008 Feb; 175(2):276-8. PubMed ID: 17379551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of Coxiella burnetii after acute primary Q fever.
    Marmion BP; Storm PA; Ayres JG; Semendric L; Mathews L; Winslow W; Turra M; Harris RJ
    QJM; 2005 Jan; 98(1):7-20. PubMed ID: 15625349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of non-specific antibacterial activity of the peritoneal cells of mice induced with Coxiella burnetii antigen.
    Tokarevich NK; Freidlin IS; Kuzina VA; Dimitrieva GM; Kaftyreva LA; Artyomenko NK
    Acta Virol; 1992 Jan; 36(1):25-31. PubMed ID: 1350168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenic and immunomodulating properties of phospholipids from Coxiella burnetii].
    Tokarevich NK; Daĭter AB; Lukacheva M; Kartseva NA
    Tr Inst Im Pastera; 1989; 66():110-8, 172-3. PubMed ID: 2485295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative characteristics of the immunogenic and immunomodulating activity of different antigenic preparations of the causative agent of Q fever Coxiella burnetii].
    Tokarevich NK; Pogodina ON; Freĭdlin IS; Kuzina VA; Kramskaia TA; Artemenko NK
    Tsitologiia; 1994; 36(11):1102-12. PubMed ID: 7535962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of chloroform/methanol extracts of Coxiella Burnetii.
    Tokarevich NK; Daiter AB; Polotsky YE; Lukácová M; Kazár J; Kartseva NA; Kuzina VA; Efremov VE; Belov AG
    Acta Virol; 1993 Feb; 37(1):29-40. PubMed ID: 8105650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers of whole Coxiella burnetii phase I by MALDI-TOF mass spectrometry.
    Shaw EI; Moura H; Woolfitt AR; Ospina M; Thompson HA; Barr JR
    Anal Chem; 2004 Jul; 76(14):4017-22. PubMed ID: 15253637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of antibodies to Coxiella burnetii antigens using immunoenzyme analysis].
    Gorbachev EN; Tokarevich NK; Fedorov DK
    Tr Inst Im Pastera; 1989; 66():127-37, 173. PubMed ID: 2485297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.
    Andoh M; Russell-Lodrigue KE; Zhang G; Samuel JE
    Ann N Y Acad Sci; 2005 Dec; 1063():167-70. PubMed ID: 16481509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.